Related by context. Frequent words. (Click for all words.) 70 Panzem R 68 Panzem R NCD 67 PLK1 SNALP 66 multi kinase inhibitor 66 Initiates Phase II 65 histone deacetylase HDAC inhibitor 65 refractory chronic lymphocytic 65 novel RNAi therapeutics 65 2 methoxyestradiol 65 Daclizumab 64 R sorafenib tablets 64 VEGFR2 inhibitor 64 Receives Orphan Drug Designation 64 Phase IIb clinical trials 64 Nanobody 64 Factor VIIa 63 topical anti infective 63 colorectal lung 63 selectively induce apoptosis 63 denufosol tetrasodium 63 inflammatory autoimmune diseases 63 cancer immunotherapies 62 vosaroxin 62 GVAX R 62 Ixempra 62 Inc. NASDAQ CRIS 62 ALN TTR 62 Drug Candidate 62 therapeutic monoclonal antibodies 62 gets USFDA nod 62 Nexavar ® 62 BZL# 62 Phase 2b clinical trials 62 ThermoDox R 62 deforolimus 62 CDP# 62 Peptimmune 62 Chemokine Therapeutics 62 Soliris TM eculizumab 62 Canvaxin 61 MKC# 61 Phase Ib IIa 61 Inc. Nasdaq IMGN 61 M Enoxaparin 61 Zolinza 61 lung pancreatic 61 Celator 61 huC# DM4 61 liposomal formulation 61 HepeX B 61 Meets Primary Endpoint 61 Vaccinex 61 targeting CD# 61 Nasdaq VRTX 61 inflammation autoimmune diseases 61 phase IIb clinical 61 novel antibody therapeutics 61 immunological diseases 61 fibrotic diseases 60 proteasome inhibitor 60 elotuzumab 60 PEGylated 60 Thiarabine 60 metastatic hormone refractory 60 immunotherapeutics 60 active cellular immunotherapy 60 Shigamabs ® 60 supplemental biologics 60 gastrointestinal mucositis 60 TELINTRA 60 PEG SN# 60 motesanib 60 AzaSite Plus 60 IMC #B 60 registrational trial 60 INTERCEPT red 60 agent VDA 60 TTR amyloidosis 60 topically delivered 60 AQ4N 60 neovascular age 60 CMV vaccine 60 advanced carcinoid 60 JAK1 60 Tolerx 60 L BLP# 60 Phase IIa trials 60 BrachySil 60 squalamine 60 Tesetaxel 60 immuno inflammatory diseases 60 investigational therapies 60 Genaera Corporation 60 Nasdaq ENZN 60 personalized immunotherapy 60 Fast Track Status 60 IMC #F# 59 cutaneous T 59 rheumatoid arthritis psoriasis 59 developing Zerenex TM 59 Diamyd ®